Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe

NeuroImage

Volumn 63, Issue 1, 2012, Pages 507-516

  Westlye, Erling Tjelta ^a   Hodneland, Erlend ^a   Haász, Judit ^a   Espeseth, Thomas ^a,b,c   Lundervold, Arvid ^a,d   Lundervold, Astri J ^a,e  

^a UNIVERSITY OF BERGEN   (Norway)

^b CENTRE FOR ADVANCED STUDY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e STATOIL   (Norway)

Author keywords

APOE; California Verbal Learning Test II; Cortical thickness; DTI; Entorhinal cortex; Hippocampus; White matter integrity

Indexed keywords

ADULT; APOE EPSILON4 GENE; ARTICLE; CORTICAL THICKNESS; DIFFUSION TENSOR IMAGING; ENTORHINAL CORTEX; EPISODIC MEMORY; FEMALE; FRACTIONAL ANISOTROPY; GENE; HETEROZYGOTE; HUMAN; MALE; MENTAL PERFORMANCE; NERVOUS SYSTEM PARAMETERS; PRIORITY JOURNAL; TEMPORAL LOBE; THREE DIMENSIONAL IMAGING; VERBAL MEMORY; WHITE MATTER;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; FEMALE; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, EPISODIC; MIDDLE AGED; ORGAN SIZE; TEMPORAL LOBE;

EID: 84864401541     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.06.072     Document Type: Article

References (106)

1. Barboriak D.P., Doraiswamy P.M., Krishnan K.R., Vidyarthi S., Sylvester J., Charles H.C. Hippocampal sulcal cavities on MRI: relationship to age and apolipoprotein E genotype. Neurology 2000, 54:2150-2153.
2. Bartzokis G., Lu P.H., Geschwind D.H., Tingus K., Huang D., Mendez M.F., Edwards N., Mintz J. Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol. Psychiatry 2007, 62:1380-1387.
3. Benjamin R., Leake A., McArthur F.K., Ince P.G., Candy J.M., Edwardson J.A., Morris C.M., Bjertness E. Protective effect of apoE epsilon 2 in Alzheimer's disease. Lancet 1994, 344:473.
4. Bloss C.S., Delis D.C., Salmon D.P., Bondi M.W. Decreased cognition in children with risk factors for Alzheimer's disease. Biol. Psychiatry 2008, 64:904-906.
5. Bobinski M., de Leon M.J., Convit A., De Santi S., Wegiel J., Tarshish C.Y., Saint Louis L.A., Wisniewski H.M. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 1999, 353:38-40.
6. Braak H., Braak E. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol. 1985, 68:325-332.
7. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
9. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. Suppl. 1996, 165:3-12.
10. Buckner R.L., Head D., Parker J., Fotenos A.F., Marcus D., Morris J.C., Snyder A.Z. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. NeuroImage 2004, 23:724-738.
11. Bucur B., Madden D.J., Spaniol J., Provenzale J.M., Cabeza R., White L.E., Huettel S.A. Age-related slowing of memory retrieval: contributions of perceptual speed and cerebral white matter integrity. Neurobiol. Aging 2008, 29:1070-1079.
12. Burggren A.C., Zeineh M.M., Ekstrom A.D., Braskie M.N., Thompson P.M., Small G.W., Bookheimer S.Y. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E ε4 carriers. NeuroImage 2008, 41:1177-1183.
13. Burwell R.D. The parahippocampal region: corticocortical connectivity. Ann. N. Y. Acad. Sci. 2000, 911:25-42.
14. Caselli R.J., Graff-Radford N.R., Reiman E.M., Weaver A., Osborne D., Lucas J., Uecker A., Thibodeau S.N. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. Neurology 1999, 53:201-207.
15. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., Baxter L.C., Rapcsak S.Z., Shi J., Woodruff B.K., Locke D.E., Snyder C.H., Alexander G.E., Rademakers R., Reiman E.M. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N. Engl. J. Med. 2009, 361:255-263.
16. Chang L., Andres M., Sadino J., Jiang C.S., Nakama H., Miller E., Ernst T. Impact of apolipoprotein E epsilon4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. NeuroImage 2011, 58:1017-1027.
17. Cherbuin N., Anstey K.J., Sachdev P.S., Maller J.J., Meslin C., Mack H.A., Wen W., Easteal S. Total and regional gray matter volume is not related to APOE*ε4 status in a community sample of middle-aged individuals. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63:501-504.
18. Christensen G.E. Deform Shape Models for Anatomy 1994, Sever Institute of Washington.
19. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
20. Dale A.M., Sereno M.I. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J. Cogn. Neurosci. 1993, 5:162-176.
21. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 1999, 9:179-194.
22. de Leon M.J., George A.E., Stylopoulos L.A., Smith G., Miller D.C. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet 1989, 2:672-673.
23. Deary I.J., Whiteman M.C., Pattie A., Starr J.M., Hayward C., Wright A.F., Carothers A., Whalley L.J. Cognitive change and the APOE epsilon 4 allele. Nature 2002, 418:932.
24. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test 2000, Psychological Corporation, San Antonio, TX. 2nd Ed.
25. Di Paolo G., Kim T.W. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 2011, 12:284-296.
26. Donix M., Burggren A.C., Suthana N.A., Siddarth P., Ekstrom A.D., Krupa A.K., Jones M., Rao A., Martin-Harris L., Ercoli L.M., Miller K.J., Small G.W., Bookheimer S.Y. Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism. NeuroImage 2010, 53:37-43.
27. Du A.T., Schuff N., Chao L.L., Kornak J., Jagust W.J., Kramer J.H., Reed B.R., Miller B.L., Norman D., Chui H.C., Weiner M.W. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol. Aging 2006, 27:733-740.
28. Espeseth T., Westlye L.T., Fjell A.M., Walhovd K.B., Rootwelt H., Reinvang I. Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol. Aging 2008, 29:329-340.
29. Espeseth T., Westlye L.T., Walhovd K.B., Fjell A.M., Endestad T., Rootwelt H., Reinvang I. Apolipoprotein E epsilon4-related thickening of the cerebral cortex modulates selective attention. Neurobiol. Aging 2012, 304-322.
30. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11050-11055.
31. Fischl B., Liu A., Dale A.M. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans. Med. Imaging 2001, 20:70-80.
32. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
33. Fischl B., Salat D.H., van der Kouwe A.J., Makris N., Segonne F., Quinn B.T., Dale A.M. Sequence-independent segmentation of magnetic resonance images. NeuroImage 2004, 23(Suppl. 1):S69-S84.
34. Fischl B., Stevens A.A., Rajendran N., Yeo B.T., Greve D.N., Van Leemput K., Polimeni J.R., Kakunoori S., Buckner R.L., Pacheco J., Salat D.H., Melcher J., Frosch M.P., Hyman B.T., Grant P.E., Rosen B.R., van der Kouwe A.J., Wiggins G.C., Wald L.L., Augustinack J.C. Predicting the location of entorhinal cortex from MRI. NeuroImage 2009, 47:8-17.
35. Fisher R.A. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika 1915, 10:507-512.
36. Fisher R.A. On the 'probable error' of a coefficient of correlation deduced from a small sample. Metron 1921, 1:3-32.
37. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
38. Frisoni G.B., Laakso M.P., Beltramello A., Geroldi C., Bianchetti A., Soininen H., Trabucchi M. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 1999, 52:91-100.
39. Gautam P., Cherbuin N., Sachdev P.S., Wen W., Anstey K.J. Relationships between cognitive function and frontal grey matter volumes and thickness in middle aged and early old-aged adults: the PATH Through Life Study. NeuroImage 2011, 55:845-855.
40. Gerdes L.U. The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin. Chem. Lab. Med. 2003, 41:628-631.
41. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996, 16:4491-4500.
42. Hafting T., Fyhn M., Bonnevie T., Moser M.B., Moser E.I. Hippocampus-independent phase precession in entorhinal grid cells. Nature 2008, 453:1248-1252.
43. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., Busa E., Pacheco J., Albert M., Killiany R., Maguire P., Rosas D., Makris N., Dale A., Dickerson B., Fischl B. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage 2006, 32:180-194.
44. Head D., Bugg J.M., Goate A.M., Fagan A.M., Mintun M.A., Benzinger T., Holtzman D.M., Morris J.C. Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch. Neurol. 2012, (E-pub ahead of print Jan 09 2012).
45. Heise V., Filippini N., Ebmeier K.P., Mackay C.E. The APOE varepsilon4 allele modulates brain white matter integrity in healthy adults. Mol. Psychiatry 2011, 16:908-916.
46. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. J. Neurosci. 2010, 30:16755-16762.
47. Hodneland E., Kjørstad Å., Andersen E., Monssen J.A., Lundervold A., Rørvik J., Munthe-Kaas A. In vivo estimation of glomerular filtration in the kidney using DCE-MRI. 7th International Symposium Image and Signal Processing and Analysis (ISPA), Dubrovnik, Croatia 2011, 755-761.
48. Hodneland E., Ystad M., Haasz J., Munthe-Kaas A., Lundervold A. Automated approaches for analysis of multimodal MRI acquisitions in a study of cognitive aging. Comput. Methods Programs Biomed. 2012, 106:328-341.
49. Honea R.A., Vidoni E., Harsha A., Burns J.M. Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J. Alzheimers Dis. 2009, 18:553-564.
50. Ihle A., Bunce D., Kliegel M. APOE epsilon4 and cognitive function in early life: a meta-analysis. Neuropsychology 2012, 26(3):267-277. (May, Epub 2012 Feb 13).
51. Jochemsen H.M., Muller M., van der Graaf Y., Geerlings M.I. APOE epsilon4 differentially influences change in memory performance depending on age. The SMART-MR study. Neurobiol. Aging 2012, 33(4):832.e15-832.e22. (Apr, Epub 2011 Sep 9).
52. Johansen-Berg H., Behrens T.E. Diffusion MRI: From Quantitative Measurement to In Vivo Neuroanatomy 2009, Academic Press, London.
53. Jovicich J., Czanner S., Greve D., Haley E., van der Kouwe A., Gollub R., Kennedy D., Schmitt F., Brown G., Macfall J., Fischl B., Dale A. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. NeuroImage 2006, 30:436-443.
54. Kennedy K.M., Raz N. Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed. Neuropsychologia 2009, 47:916-927.
55. Klauschen F., Goldman A., Barra V., Meyer-Lindenberg A., Lundervold A. Evaluation of automated brain MR image segmentation and volumetry methods. Hum. Brain Mapp. 2009, 30:1310-1327.
56. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat. Rev. Neurosci. 2003, 4:469-480.
57. Ma F., Wang J., Miao R., Zhao W., Wang Q. Association between apolipoprotein E epsilon4 and longitudinal cognitive decline: nested case-control study among Chinese community-dwelling elders. Neuropsychobiology 2011, 64:102-109.
58. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
59. Modersitzki J. FAIR: Flexible Algorithms for Image Registration 2009, SIAM, Philadelphia.
60. Morris J.C., Roe C.M., Xiong C., Fagan A.M., Goate A.M., Holtzman D.M., Mintun M.A. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann. Neurol. 2010, 67:122-131.
61. Mueller S.G., Weiner M.W. Selective effect of age, Apo ε4, and Alzheimer's disease on hippocampal subfields. Hippocampus 2009, 19:558-564.
62. Mueller S.G., Schuff N., Raptentsetsang S., Elman J., Weiner M.W. Selective effect of Apo ε4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4T. NeuroImage 2008, 42:42-48.
63. Nierenberg J., Pomara N., Hoptman M.J., Sidtis J.J., Ardekani B.A., Lim K.O. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. Neuroreport 2005, 16:1369-1372.
64. Okuizumi K., Onodera O., Tanaka H., Kobayashi H., Tsuji S., Takahashi H., Oyanagi K., Seki K., Tanaka M., Naruse S., et al. ApoE-epsilon 4 and early-onset Alzheimer's. Nat. Genet. 1994, 7:10-11.
65. Packard C.J., Westendorp R.G., Stott D.J., Caslake M.J., Murray H.M., Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., Ford I., Gaw A., Hyland M., Jukema J.W., Kamper A.M., Macfarlane P.W., Jolles J., Perry I.J., Sweeney B.J., Twomey C. Association between apolipoprotein ε4 and cognitive decline in elderly adults. J. Am. Geriatr. Soc. 2007, 55:1777-1785.
66. Panizzon M.S., Fennema-Notestine C., Eyler L.T., Jernigan T.L., Prom-Wormley E., Neale M., Jacobson K., Lyons M.J., Grant M.D., Franz C.E., Xian H., Tsuang M., Fischl B., Seidman L., Dale A., Kremen W.S. Distinct genetic influences on cortical surface area and cortical thickness. Cereb. Cortex 2009, 19:2728-2735.
67. Panza F., Frisardi V., Imbimbo B.P., Seripa D., Paris F., Santamato A., D'Onofrio G., Logroscino G., Pilotto A., Solfrizzi V. Anti-beta-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab. Curr. Alzheimer Res. 2011, 8:808-817.
68. Persson J., Lind J., Larsson A., Ingvar M., Cruts M., Van Broeckhoven C., Adolfsson R., Nilsson L.G., Nyberg L. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?. Neurology 2006, 66:1029-1033.
69. Reiman E.M., Uecker A., Caselli R.J., Lewis S., Bandy D., de Leon M.J., De Santi S., Convit A., Osborne D., Weaver A., Thibodeau S.N. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann. Neurol. 1998, 44:288-291.
70. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S.A., Langbaum J.B., Alexander G.E., Klunk W.E., Mathis C.A., Price J.C., Aizenstein H.J., DeKosky S.T., Caselli R.J. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6820-6825.
71. Reinvang I., Winjevoll I.L., Rootwelt H., Espeseth T. Working memory deficits in healthy APOE epsilon 4 carriers. Neuropsychologia 2010, 48:566-573.
72. Roses A.D. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 1996, 47:387-400.
73. Ryan L., Walther K., Bendlin B.B., Lue L.F., Walker D.G., Glisky E.L. Age-related differences in white matter integrity and cognitive function are related to APOE status. NeuroImage 2011, 54:1565-1577.
74. Schiepers O.J., Harris S.E., Gow A.J., Pattie A., Brett C.E., Starr J.M., Deary I.J. APOE ε4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921. Mol. Psychiatry 2012, 17(3):315-324. (Mar, Epub 2011 Jan 25). http://dx.doi.org/10.1038/mp.2010.137.
75. Schmidt H., Schmidt R., Fazekas F., Semmler J., Kapeller P., Reinhart B., Kostner G.M. Apolipoprotein E ε4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin. Genet. 1996, 50:293-299.
76. Segonne F., Dale A.M., Busa E., Glessner M., Salat D., Hahn H.K., Fischl B. A hybrid approach to the skull stripping problem in MRI. NeuroImage 2004, 22:1060-1075.
77. Shaw P., Greenstein D., Lerch J., Clasen L., Lenroot R., Gogtay N., Evans A., Rapoport J., Giedd J. Intellectual ability and cortical development in children and adolescents. Nature 2006, 440:676-679.
78. Shaw P., Lerch J.P., Pruessner J.C., Taylor K.N., Rose A.B., Greenstein D., Clasen L., Evans A., Rapoport J.L., Giedd J.N. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 2007, 6:494-500.
79. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6037-6042.
80. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 2011, 12:585-601.
81. Solstad T., Boccara C.N., Kropff E., Moser M.B., Moser E.I. Representation of geometric borders in the entorhinal cortex. Science 2008, 322:1865-1868.
82. SPSS PASW 18, formerly SPSS (Statistical Package for the Social Sciences) 2009.
83. Squire L.R., Wixted J.T. The cognitive neuroscience of human memory since H.M. Annu. Rev. Neurosci. 2011, 34:259-288.
84. Squire L.R., Stark C.E., Clark R.E. The medial temporal lobe. Annu. Rev. Neurosci. 2004, 27:279-306.
85. Stebbins G.T., Murphy C.M. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav. Neurol. 2009, 21:39-49.
86. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:1977-1981.
87. Sunderland T., Mirza N., Putnam K.T., Linker G., Bhupali D., Durham R., Soares H., Kimmel L., Friedman D., Bergeson J., Csako G., Levy J.A., Bartko J.J., Cohen R.M. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol. Psychiatry 2004, 56:670-676.
88. Suzuki W.A., Amaral D.G. Functional neuroanatomy of the medial temporal lobe memory system. Cortex 2004, 40:220-222.
89. Taylor A.E., Guthrie P.A., Smith G.D., Golding J., Sattar N., Hingorani A.D., Deanfield J.E., Day I.N. IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children. Biol. Psychiatry 2011, 70:152-158.
90. Thompson W.K., Hallmayer J., O'Hara R. Design considerations for characterizing psychiatric trajectories across the lifespan: application to effects of APOE-epsilon4 on cerebral cortical thickness in Alzheimer's disease. Am. J. Psychiatry 2011, 168:894-903.
91. Tiraboschi P., Hansen L.A., Masliah E., Alford M., Thal L.J., Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 2004, 62:1977-1983.
92. Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B., Zlokovic B., Smith J.D., Ladu M.J., Rostagno A., Frangione B., Ghiso J. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem. J. 2000, 348(Pt 2):359-365.
93. Trachtenberg A.J., Filippini N., Ebmeier K.P., Smith S.M., Karpe F., Mackay C.E. The effects of APOE on the functional architecture of the resting brain. NeuroImage 2012, 59:565-572.
94. Tuminello E.R., Han S.D. The apolipoprotein E antagonistic pleiotropy hypothesis: review and recommendations. Int. J. Alzheimers Dis. 2011, 2011:726197.
95. Van Petten C. Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. Neuropsychologia 2004, 42:1394-1413.
96. van Strien N.M., Cappaert N.L., Witter M.P. The anatomy of memory: an interactive overview of the parahippocampal-hippocampal network. Nat. Rev. Neurosci. 2009, 10:272-282.
97. Wenk G.L. Neuropathologic changes in Alzheimer's disease. J. Clin. Psychiatry 2003, 64(Suppl. 9):7-10.
98. Williams P.D., Day T. Antagonistic pleiotropy, mortality source interactions, and the evolutionary theory of senescence. Evolution 2003, 57:1478-1488.
99. Wilson R.S., Bienias J.L., Berry-Kravis E., Evans D.A., Bennett D.A. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J. Neurol. Neurosurg. Psychiatry 2002, 73:672-677.
100. Wilson R.S., Schneider J.A., Barnes L.L., Beckett L.A., Aggarwal N.T., Cochran E.J., Berry-Kravis E., Bach J., Fox J.H., Evans D.A., Bennett D.A. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol. 2002, 59:1154-1160.
101. Winkler A.M., Kochunov P., Blangero J., Almasy L., Zilles K., Fox P.T., Duggirala R., Glahn D.C. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. NeuroImage 2010, 53:1135-1146.
102. Wisdom N.M., Callahan J.L., Hawkins K.A. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol. Aging 2011, 32:63-74.
103. Wishart H.A., Saykin A.J., McAllister T.W., Rabin L.A., McDonald B.C., Flashman L.A., Roth R.M., Mamourian A.C., Tsongalis G.J., Rhodes C.H. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006, 67:1221-1224.
104. Yassa M.A., Muftuler L.T., Stark C.E. Ultrahigh-resolution microstructural diffusion tensor imaging reveals perforant path degradation in aged humans in vivo. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12687-12691.
105. Yassa M.A., Mattfeld A.T., Stark S.M., Stark C.E. Age-related memory deficits linked to circuit-specific disruptions in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8873-8878.
106. Ziegler D.A., Piguet O., Salat D.H., Prince K., Connally E., Corkin S. Cognition in healthy aging is related to regional white matter integrity, but not cortical thickness. Neurobiol. Aging 2010, 31:1912-1926.